These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 28646072)

  • 1. Genetic and Environmental Interactions Modify the Risk of Diabetes-Related Autoimmunity by 6 Years of Age: The TEDDY Study.
    Krischer JP; Lynch KF; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Akolkar B;
    Diabetes Care; 2017 Sep; 40(9):1194-1202. PubMed ID: 28646072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of the Initiation of Islet Autoimmunity and Progression to Multiple Autoantibodies and Clinical Diabetes: The TEDDY Study.
    Krischer JP; Liu X; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Akolkar B;
    Diabetes Care; 2022 Oct; 45(10):2271-2281. PubMed ID: 36150053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-appearing islet autoantibodies for type 1 diabetes in young children: maternal life events during pregnancy and the child's genetic risk.
    Johnson SB; Lynch KF; Roth R; Lundgren M; Parikh HM; Akolkar B; Hagopian W; Krischer J; Rewers M; She JX; Toppari J; Ziegler AG; Lernmark Å;
    Diabetologia; 2021 Mar; 64(3):591-602. PubMed ID: 33404683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Islet Cell Autoimmunity and Type 1 Diabetes: An 8-Year TEDDY Study Progress Report.
    Krischer JP; Liu X; Vehik K; Akolkar B; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Lernmark Å;
    Diabetes Care; 2019 Jun; 42(6):1051-1060. PubMed ID: 30967432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between deduced first islet specific autoantibody with sex, age at diagnosis and genetic risk factors in young children with type 1 diabetes.
    Ilonen J; Laine AP; Kiviniemi M; Härkönen T; Lempainen J; Knip M;
    Pediatr Diabetes; 2022 Sep; 23(6):693-702. PubMed ID: 35403376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children.
    Achenbach P; Hummel M; Thümer L; Boerschmann H; Höfelmann D; Ziegler AG
    Diabetologia; 2013 Jul; 56(7):1615-22. PubMed ID: 23539116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study.
    Vehik K; Bonifacio E; Lernmark Å; Yu L; Williams A; Schatz D; Rewers M; She JX; Toppari J; Hagopian W; Akolkar B; Ziegler AG; Krischer JP;
    Diabetes Care; 2020 Sep; 43(9):2066-2073. PubMed ID: 32641373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher prevalence of autoantibodies to insulin and GAD65 in Swedish compared to Lithuanian children with type 1 diabetes.
    Holmberg H; Vaarala O; Sadauskaite-Kuehne V; Ilonen J; Padaiga Z; Ludvigsson J
    Diabetes Res Clin Pract; 2006 Jun; 72(3):308-14. PubMed ID: 16442659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study.
    Krischer JP; Lynch KF; Schatz DA; Ilonen J; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Simell OG; Toppari J; Ziegler AG; Akolkar B; Bonifacio E;
    Diabetologia; 2015 May; 58(5):980-7. PubMed ID: 25660258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity.
    Ilonen J; Lempainen J; Hammais A; Laine AP; Härkönen T; Toppari J; Veijola R; Knip M;
    Pediatr Diabetes; 2018 Mar; 19(2):284-292. PubMed ID: 28597949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
    El-Amir MI; El-Feky MA; Laine AP; Härkönen T; El-Badawy O; Eltayeb AA; El-Melegy TT; Kiviniemi M; Knip M; Ilonen J
    Diabetes Metab Res Rev; 2015 Mar; 31(3):287-94. PubMed ID: 25256132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between the PTPN22 1858C>T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies.
    Maziarz M; Janer M; Roach JC; Hagopian W; Palmer JP; Deutsch K; Sanjeevi CB; Kockum I; Breslow N; Lernmark A; ;
    Genes Immun; 2010 Jul; 11(5):406-15. PubMed ID: 20445565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3.
    Petrone A; Suraci C; Capizzi M; Giaccari A; Bosi E; Tiberti C; Cossu E; Pozzilli P; Falorni A; Buzzetti R;
    Diabetes Care; 2008 Mar; 31(3):534-8. PubMed ID: 18056891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age at Seroconversion, HLA Genotype, and Specificity of Autoantibodies in Progression of Islet Autoimmunity in Childhood.
    Bauer W; Veijola R; Lempainen J; Kiviniemi M; Härkönen T; Toppari J; Knip M; Gyenesei A; Ilonen J
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4521-4530. PubMed ID: 31120497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes.
    Hermann R; Lipponen K; Kiviniemi M; Kakko T; Veijola R; Simell O; Knip M; Ilonen J
    Diabetologia; 2006 Jun; 49(6):1198-208. PubMed ID: 16614815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of polymorphisms in non-HLA loci with autoantibodies at the diagnosis of type 1 diabetes: INS and IKZF4 associate with insulin autoantibodies.
    Lempainen J; Härkönen T; Laine A; Knip M; Ilonen J;
    Pediatr Diabetes; 2013 Nov; 14(7):490-6. PubMed ID: 23721563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic risk markers related to diabetes-associated autoantibodies in young patients with type 1 diabetes in berlin, Germany.
    Kordonouri O; Hartmann R; Charpentier N; Knip M; Danne T; Ilonen J
    Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):245-9. PubMed ID: 20140847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of High-Affinity Autoantibodies With Type 1 Diabetes High-Risk HLA Haplotypes.
    Triolo TM; Pyle L; Broncucia H; Armstrong T; Yu L; Gottlieb PA; Steck AK
    J Clin Endocrinol Metab; 2022 Mar; 107(4):e1510-e1517. PubMed ID: 34850014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DR-DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity.
    Mikk ML; Pfeiffer S; Kiviniemi M; Laine AP; Lempainen J; Härkönen T; Toppari J; Veijola R; Knip M; Ilonen J;
    Pediatr Diabetes; 2020 Nov; 21(7):1218-1226. PubMed ID: 32613719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.